-
1
-
-
70350245011
-
Harmonizing the metabolic syndrome a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity
-
1:CAS:528:DC%2BD1MXht1OrtrrK
-
Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640-5.
-
(2009)
Circulation
, vol.120
, pp. 1640-1645
-
-
Alberti, K.1
Eckel, R.H.2
Grundy, S.M.3
Zimmet, P.Z.4
Cleeman, J.I.5
Donato, K.A.6
-
2
-
-
21544462572
-
Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome a summary of the evidence
-
Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome a summary of the evidence. Diabetes Care. 2005;28:1769-78.
-
(2005)
Diabetes Care
, vol.28
, pp. 1769-1778
-
-
Ford, E.S.1
-
3
-
-
27444433127
-
Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults
-
Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134-40.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2134-2140
-
-
Kurella, M.1
Lo, J.C.2
Chertow, G.M.3
-
4
-
-
84919459420
-
Insulin resistance is associated with new-onset cardiovascular events in nondiabetic patients undergoing peritoneal dialysis
-
Yoon C-Y, Lee MJ, Kee YK, Lee E, Joo YS, Han IM, et al. Insulin resistance is associated with new-onset cardiovascular events in nondiabetic patients undergoing peritoneal dialysis. Kidney Res Clin Pract. 2014;33:192-8.
-
(2014)
Kidney Res Clin Pract.
, vol.33
, pp. 192-198
-
-
Yoon, C.-Y.1
Lee, M.J.2
Kee, Y.K.3
Lee, E.4
Joo, Y.S.5
Han, I.M.6
-
5
-
-
33645501804
-
Adiponectin-a key adipokine in the metabolic syndrome
-
1:CAS:528:DC%2BD28XkvVajuro%3D
-
Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin-a key adipokine in the metabolic syndrome. Diabetes Obes Metab. 2006;8:264-80.
-
(2006)
Diabetes Obes Metab
, vol.8
, pp. 264-280
-
-
Whitehead, J.P.1
Richards, A.A.2
Hickman, I.J.3
Macdonald, G.A.4
Prins, J.B.5
-
6
-
-
17944365228
-
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
-
1:CAS:528:DC%2BD3MXlvVOkt7o%3D
-
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-6.
-
(2001)
Nat Med
, vol.7
, pp. 941-946
-
-
Yamauchi, T.1
Kamon, J.2
Waki, H.3
Terauchi, Y.4
Kubota, N.5
Hara, K.6
-
8
-
-
23844557141
-
Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin
-
1:CAS:528:DC%2BD2MXnvVWksrc%3D
-
Pilz S, Horejsi R, Möller R, Almer G, Scharnagl H, Stojakovic T, et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab. 2005;90:4792-6.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 4792-4796
-
-
Pilz, S.1
Horejsi, R.2
Möller, R.3
Almer, G.4
Scharnagl, H.5
Stojakovic, T.6
-
9
-
-
79960691183
-
Association of adiponectin with carotid arteriosclerosis in predialysis chronic kidney disease
-
1:CAS:528:DC%2BC3MXhtFykt7zF
-
Hayashi M, Shibata R, Takahashi H, Ishii H, Aoyama T, Kasuga H, et al. Association of adiponectin with carotid arteriosclerosis in predialysis chronic kidney disease. Am J Nephrol. 2011;34:249-55.
-
(2011)
Am J Nephrol
, vol.34
, pp. 249-255
-
-
Hayashi, M.1
Shibata, R.2
Takahashi, H.3
Ishii, H.4
Aoyama, T.5
Kasuga, H.6
-
10
-
-
78649952873
-
Insulin resistance and lower plasma adiponectin increase malignancy risk in nondiabetic continuous ambulatory peritoneal dialysis patients
-
1:CAS:528:DC%2BC3cXhsFamt7rJ
-
Park JT, Yoo TH, Chang TI, Lee DH, Lee JH, Lee JE, et al. Insulin resistance and lower plasma adiponectin increase malignancy risk in nondiabetic continuous ambulatory peritoneal dialysis patients. Metabolism. 2011;60:121-6.
-
(2011)
Metabolism
, vol.60
, pp. 121-126
-
-
Park, J.T.1
Yoo, T.H.2
Chang, T.I.3
Lee, D.H.4
Lee, J.H.5
Lee, J.E.6
-
11
-
-
33748050124
-
Adiponectin and mortality in patients with chronic kidney disease
-
1:CAS:528:DC%2BD28XpvFOnsL4%3D
-
Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2599-606.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 2599-2606
-
-
Menon, V.1
Li, L.2
Wang, X.3
Greene, T.4
Balakrishnan, V.5
Madero, M.6
-
12
-
-
84902382706
-
KNOW-CKD (KoreaN cohort study for outcome in patients with chronic kidney disease): design and methods
-
Oh K-H, Park SK, Park HC, Chin HJ, Chae DW, Choi KH, et al. KNOW-CKD (KoreaN cohort study for outcome in patients with chronic kidney disease): design and methods. BMC Nephrol. 2014;15:80.
-
(2014)
BMC Nephrol.
, vol.15
, pp. 80
-
-
Oh, K.-H.1
Park, S.K.2
Park, H.C.3
Chin, H.J.4
Chae, D.W.5
Choi, K.H.6
-
13
-
-
0015363180
-
Indices of relative weight and obesity
-
1:STN:280:DyaE3s%2Fpt12mtw%3D%3D
-
Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis. 1972;25:329-43.
-
(1972)
J Chronic Dis.
, vol.25
, pp. 329-343
-
-
Keys, A.1
Fidanza, F.2
Karvonen, M.J.3
Kimura, N.4
Taylor, H.L.5
-
14
-
-
33747120659
-
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
-
1:CAS:528:DC%2BD28XpsFejtbo%3D
-
Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-54.
-
(2006)
Ann Intern Med
, vol.145
, pp. 247-254
-
-
Levey, A.S.1
Coresh, J.2
Greene, T.3
Stevens, L.A.4
Zhang, Y.L.5
Hendriksen, S.6
-
15
-
-
33746338594
-
A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population
-
Hara K, Matsushita Y, Horikoshi M, Yoshiike N, Yokoyama T, Tanaka H, et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care. 2006;29:1123-4.
-
(2006)
Diabetes Care
, vol.29
, pp. 1123-1124
-
-
Hara, K.1
Matsushita, Y.2
Horikoshi, M.3
Yoshiike, N.4
Yokoyama, T.5
Tanaka, H.6
-
17
-
-
34250026176
-
Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the mild to moderate kidney disease study
-
1:STN:280:DC%2BD2szjvFOktw%3D%3D
-
Kollerits B, Fliser D, Heid IM, Ritz E, Kronenberg F. Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the mild to moderate kidney disease study. Kidney Int. 2007;71:1279-86.
-
(2007)
Kidney Int
, vol.71
, pp. 1279-1286
-
-
Kollerits, B.1
Fliser, D.2
Heid, I.M.3
Ritz, E.4
Kronenberg, F.5
-
18
-
-
78650707102
-
Adiponectin in chronic kidney disease: a complex and context sensitive clinical situation
-
1:CAS:528:DC%2BC3MXhsFKhsQ%3D%3D
-
Stenvinkel P. Adiponectin in chronic kidney disease: a complex and context sensitive clinical situation. J Ren Nutr. 2011;21:82-6.
-
(2011)
J Ren Nutr.
, vol.21
, pp. 82-86
-
-
Stenvinkel, P.1
-
19
-
-
17744420209
-
Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors
-
Zoccali C, Mallamaci F, Panuccio V, Tripepi G, Cutrupi S, Parlongo S, et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int Suppl. 2003. doi:10.1046/j.1523-1755.63.s84.49.x.S98-102.
-
(2003)
Kidney Int Suppl
-
-
Zoccali, C.1
Mallamaci, F.2
Panuccio, V.3
Tripepi, G.4
Cutrupi, S.5
Parlongo, S.6
-
20
-
-
12444285803
-
Plasma adiponectin concentration before and after successful kidney transplantation
-
1:CAS:528:DC%2BD3sXnslSrtr8%3D
-
Chudek J, Adamczak M, Karkoszka H, Budzinski G, Ignacy W, Funahashi T, et al. Plasma adiponectin concentration before and after successful kidney transplantation. Transpl Proc. 2003;35:2186-9.
-
(2003)
Transpl Proc.
, vol.35
, pp. 2186-2189
-
-
Chudek, J.1
Adamczak, M.2
Karkoszka, H.3
Budzinski, G.4
Ignacy, W.5
Funahashi, T.6
-
21
-
-
73849107696
-
High-salt diet increases plasma adiponectin levels independent of blood pressure in hypertensive rats: the role of the renin-angiotensin-aldosterone system
-
1:CAS:528:DC%2BD1MXhsFKgu73K
-
Kamari Y, Shimoni N, Koren F, Peleg E, Sharabi Y, Grossman E. High-salt diet increases plasma adiponectin levels independent of blood pressure in hypertensive rats: the role of the renin-angiotensin-aldosterone system. J Hypertens. 2010;28:95-101.
-
(2010)
J Hypertens
, vol.28
, pp. 95-101
-
-
Kamari, Y.1
Shimoni, N.2
Koren, F.3
Peleg, E.4
Sharabi, Y.5
Grossman, E.6
-
22
-
-
34447318485
-
Adiponectin and renal function, and implication as a risk of cardiovascular disease
-
1:CAS:528:DC%2BD28Xht1Kks7bN
-
Iwashima Y, Horio T, Kumada M, Suzuki Y, Kihara S, Rakugi H, et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol. 2006;98:1603-8.
-
(2006)
Am J Cardiol
, vol.98
, pp. 1603-1608
-
-
Iwashima, Y.1
Horio, T.2
Kumada, M.3
Suzuki, Y.4
Kihara, S.5
Rakugi, H.6
-
23
-
-
56349100160
-
Adiponectin stimulates phosphorylation of AMP-activated protein kinase alpha in renal glomeruli
-
1:CAS:528:DC%2BD1cXhtlyks7rN
-
Cammisotto PG, Bendayan M. Adiponectin stimulates phosphorylation of AMP-activated protein kinase alpha in renal glomeruli. J Mol Histol. 2008;39:579-84.
-
(2008)
J Mol Histol
, vol.39
, pp. 579-584
-
-
Cammisotto, P.G.1
Bendayan, M.2
-
24
-
-
34548155517
-
Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice
-
1:CAS:528:DC%2BD2sXpt1Cis7o%3D
-
Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol. 2007;27:1910-7.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 1910-1917
-
-
Ohashi, K.1
Iwatani, H.2
Kihara, S.3
Nakagawa, Y.4
Komura, N.5
Fujita, K.6
-
25
-
-
84889562368
-
Changes of adiponectin and its receptors in rats following chronic renal failure
-
1:CAS:528:DC%2BC3sXhvVOgtL7M
-
Yu Y, Bao BJ, Fan YP, Shi L, Li SQ. Changes of adiponectin and its receptors in rats following chronic renal failure. Ren Fail. 2014;36:92-7.
-
(2014)
Ren Fail
, vol.36
, pp. 92-97
-
-
Yu, Y.1
Bao, B.J.2
Fan, Y.P.3
Shi, L.4
Li, S.Q.5
-
26
-
-
1842864234
-
Plasma adiponectin levels and risk of myocardial infarction in men
-
1:CAS:528:DC%2BD2cXjt1Wrt7Y%3D
-
Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730-7.
-
(2004)
JAMA
, vol.291
, pp. 1730-1737
-
-
Pischon, T.1
Girman, C.J.2
Hotamisligil, G.S.3
Rifai, N.4
Hu, F.B.5
Rimm, E.B.6
-
27
-
-
25444506344
-
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure
-
1:CAS:528:DC%2BD2MXpvFGqsLw%3D
-
Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005;112:1756-62.
-
(2005)
Circulation
, vol.112
, pp. 1756-1762
-
-
Kistorp, C.1
Faber, J.2
Galatius, S.3
Gustafsson, F.4
Frystyk, J.5
Flyvbjerg, A.6
-
28
-
-
0030972278
-
Wasting as independent risk factor for mortality in chronic heart failure
-
1:STN:280:DyaK2s3mtFarug%3D%3D
-
Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050-3.
-
(1997)
Lancet
, vol.349
, pp. 1050-1053
-
-
Anker, S.D.1
Ponikowski, P.2
Varney, S.3
Chua, T.P.4
Clark, A.L.5
Webb-Peploe, K.M.6
-
29
-
-
33845997778
-
Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease
-
1:CAS:528:DC%2BD2sXivFCqsA%3D%3D
-
Shen YY, Charlesworth JA, Kelly JJ, Loi KW, Peake PW. Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease. Nephrol Dial Transpl. 2007;22:171-8.
-
(2007)
Nephrol Dial Transpl
, vol.22
, pp. 171-178
-
-
Shen, Y.Y.1
Charlesworth, J.A.2
Kelly, J.J.3
Loi, K.W.4
Peake, P.W.5
-
30
-
-
34547747342
-
Does adiponectin resistance exist in chronic heart failure?
-
Kintscher U. Does adiponectin resistance exist in chronic heart failure? Eur Heart J. 2007;28:1676-7.
-
(2007)
Eur Heart J
, vol.28
, pp. 1676-1677
-
-
Kintscher, U.1
-
31
-
-
84871896976
-
Reprint of "paradoxical decrease of an adipose-specific protein, adiponectin, in obesity"
-
1:CAS:528:DC%2BC38Xht1KrsrvM
-
Arita Y. Reprint of "paradoxical decrease of an adipose-specific protein, adiponectin, in obesity". Biochem Biophys Res Commun. 2012;425:560-4.
-
(2012)
Biochem Biophys Res Commun.
, vol.425
, pp. 560-564
-
-
Arita, Y.1
-
32
-
-
0034891684
-
Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin
-
1:CAS:528:DC%2BD3MXlvFekurs%3D
-
Yang W-S, Lee W-J, Funahashi T, Tanaka S, Matsuzawa Y, Chao C-L, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86:3815-9.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 3815-3819
-
-
Yang, W.-S.1
Lee, W.-J.2
Funahashi, T.3
Tanaka, S.4
Matsuzawa, Y.5
Chao, C.-L.6
-
33
-
-
0034769377
-
The relation of body fat mass and distribution to markers of chronic inflammation
-
1:STN:280:DC%2BD3Mrms1Gjug%3D%3D
-
Festa A, D'Agostino R Jr, Williams K, Karter A, Mayer-Davis E, Tracy R, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25:1407-15.
-
(2001)
Int J Obes Relat Metab Disord
, vol.25
, pp. 1407-1415
-
-
Festa, A.1
D'Agostino, R.2
Williams, K.3
Karter, A.4
Mayer-Davis, E.5
Tracy, R.6
-
34
-
-
85003706957
-
Serum adiponectin and protein-energy wasting in predialysis chronic kidney disease
-
Hyun YY, Lee KB, Oh KH, Ahn C, Park SK, Chae DW, et al. Serum adiponectin and protein-energy wasting in predialysis chronic kidney disease. Nutrition. 2016. doi:10.1016/j.nut.2016.06.014.
-
(2016)
Nutrition.
-
-
Hyun, Y.Y.1
Lee, K.B.2
Oh, K.H.3
Ahn, C.4
Park, S.K.5
Chae, D.W.6
-
35
-
-
84930926907
-
High serum adiponectin is associated with low blood haemoglobin in elderly men: the Swedish MrOS study
-
1:CAS:528:DC%2BC2MXhtVehu7fK
-
Lewerin C, Johansson H, Lerner UH, Karlsson MK, Lorentzon M, Barrett-Connor E, et al. High serum adiponectin is associated with low blood haemoglobin in elderly men: the Swedish MrOS study. J Intern Med. 2015;278:68-76.
-
(2015)
J Intern Med
, vol.278
, pp. 68-76
-
-
Lewerin, C.1
Johansson, H.2
Lerner, U.H.3
Karlsson, M.K.4
Lorentzon, M.5
Barrett-Connor, E.6
-
36
-
-
70249098457
-
Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction
-
1:CAS:528:DC%2BD1MXhtFGhsLvE
-
Aso Y, Suganuma R, Wakabayashi S, Hara K, Nakano T, Suetsugu M, et al. Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction. Transl Res. 2009;154:175-82.
-
(2009)
Transl Res.
, vol.154
, pp. 175-182
-
-
Aso, Y.1
Suganuma, R.2
Wakabayashi, S.3
Hara, K.4
Nakano, T.5
Suetsugu, M.6
-
37
-
-
39749087544
-
Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury
-
1:CAS:528:DC%2BD1cXit1yhtbk%3D
-
Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler AA 3rd. Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury. J Cardiovasc Pharmacol. 2008;51:178-87.
-
(2008)
J Cardiovasc Pharmacol
, vol.51
, pp. 178-187
-
-
Natarajan, R.1
Salloum, F.N.2
Fisher, B.J.3
Kukreja, R.C.4
Fowler, A.A.5
-
39
-
-
67650504733
-
Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment
-
1:CAS:528:DC%2BD1MXntV2js78%3D
-
Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009;460:259-63.
-
(2009)
Nature
, vol.460
, pp. 259-263
-
-
Naveiras, O.1
Nardi, V.2
Wenzel, P.L.3
Hauschka, P.V.4
Fahey, F.5
Daley, G.Q.6
-
40
-
-
18644369745
-
Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians
-
1:CAS:528:DC%2BD38XnvVemtrk%3D
-
Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet. 2002;11:2607-14.
-
(2002)
Hum Mol Genet
, vol.11
, pp. 2607-2614
-
-
Vasseur, F.1
Helbecque, N.2
Dina, C.3
Lobbens, S.4
Delannoy, V.5
Gaget, S.6
|